Sentence examples for expected to relapse from inspiring English sources

Despite representing a progress with respect to other regimens, virtually all patients are expected to relapse.

However, cure rates have not shown a substantial improvement even in the chemosensitive setting (Vaughan et al, 2011) and the majority of patients with advanced stage disease is expected to relapse and develop a drug-resistant disease.

The SSS cost approximately £950 per successful 1‐year quitter based on the total cost of SSS between April 2002 and March 2010 34 and number of biochemically verified 4‐week quitters using SSS and the proportion expected to relapse after 1 year 35.

The total amount of chemotherapy administered with a policy of adjuvant chemotherapy (200 cycles per 100 high-risk patients) is now considerably higher than a policy of surveillance, with three courses of chemotherapy for the 40% expected to relapse (∼120 cycles per 100 high-risk patients).

Approximately 30% of all patients with RCC has metastatic disease at presentation and ~50% of patients undergoing curative surgery can be expected to experience relapse at distant sites [ 2, 3].

Newly diagnosed patients were expected to improve, relapsed patients to deteriorate and patients with a stable disease to stay unchanged.

On the other hand, it is just as unnecessary to plan annual follow-up visits with imaging tools for good risk testicular cancer patients for 20 years, for example, as very few patients are expected to have relapsed after 2 years.

Our EpCAM IMS assay therefore detects cells in SLNs of far more patients than those who can be expected to suffer from relapse later.

While localised disease is potentially curable, even in stage I and II disease, 30%% of patients can be expected to experience a relapse [ 3].

Few economists expect Germany to relapse into recession, but the Ifo Institute's closely followed survey of business confidence has shown a decline for two consecutive months.

The artemisinin component of DP contributes significantly to the initial therapeutic response but would not be expected to affect subsequent relapses or reinfections.